Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - TENET HEALTHCARE CORPtenetnewdirectorsrelease_1.htm
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 _______________
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 _______________
Date of Report:  November 8, 2017
(Date of earliest event reported)
 _______________
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
 
 
 
 
 
Nevada
 
1-7293
 
95-2557091
(State of Incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification Number)
1445 Ross Avenue, Suite 1400
Dallas, Texas 75202
(Address of principal executive offices, including zip code)
(469) 893-2200
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging Growth Company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ¨

 
 
 




Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements Of Certain Officers.

On November 8, 2017, the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”) appointed Richard W. Fisher and Richard J. Mark as independent members of the Board. Mr. Fisher and Mr. Mark will stand for election as independent directors at the Company’s 2018 annual meeting of shareholders.

Mr. Fisher and Mr. Mark will participate in the non-employee director compensation programs described under “Director Compensation” in the Company’s proxy statement filed with the SEC on March 24, 2017. There are no arrangements or understandings pursuant to which either of Mr. Fisher or Mr. Mark was appointed to the Board, and neither Mr. Fisher nor Mr. Mark is a party to any transaction with the Company reportable under Item 404(a) of Regulation S-K under the Securities Act of 1933.

A copy of the Company’s press release announcing the appointments of Mr. Fisher and Mr. Mark is filed as Exhibit 99.1 to this Form 8-K.

Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
 
Description
99.1
 







SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
TENET HEALTHCARE CORPORATION
 
 
 
 
Date: November 9, 2017
 
By:
 
/s/ PAUL A. CASTANON
 
 
 
 
Paul A. Castanon
 
 
 
 
Vice President, Deputy General Counsel and Corporate Secretary